AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Cash on Hand 2019–2025
AbCellera Biologics Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- AbCellera Biologics Inc. cash on hand for the quarter ending December 31, 2025 were 128.5M, a 17.79% decrease year-over-year.
- AbCellera Biologics Inc. cash on hand for 2025 were 128.5M, a 17.79% decrease from 2024.
- AbCellera Biologics Inc. cash on hand for 2024 were 156.3M, a 17.26% increase from 2023.
- AbCellera Biologics Inc. cash on hand for 2023 were 133.3M, a 65.51% decrease from 2022.
- AbCellera Biologics Inc. cash on hand for 2022 were 386.5M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| AbCellera Biologics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $129 |
| 2024 | $156 |
| 2023 | $133 |
| 2022 | $387 |
| 2021 | $476 |
| 2020 | $594 |
| AbCellera Biologics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $129 |
| 2024-12-31 | $156 |
| 2023-12-31 | $133 |
| 2022-12-31 | $387 |
| 2021-12-31 | $476 |
| 2020-12-31 | $594 |
AbCellera Biologics Inc. Cash on Hand — FAQ
AbCellera Biologics Inc. (ABCL) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's cash on hand history?
The chart and table above show AbCellera Biologics Inc.'s cash on hand by year and by quarter, including the growth rate.